Navigation Links
Biopharm Insight Hosts Educational Webinar Ahead of American Society of Hematology Conference Next Month
Date:11/13/2013

Norwood, MA (PRWEB) November 13, 2013

BioPharm Insight, a division of Infinata, will host an educational webinar to unveil highlights ahead of the American Society of Hematology (ASH) Annual Conference next month. The ASH Conference takes place December 7-10 in New Orleans.

Webinar: BioPharm Insight’s Pre-ASH Crash Course
Speaker: Juliana Wexler, Oncology Reporter
Date & Time: November 21, 10:00 AM EST
Register: http://goo.gl/5ij5j9

The webinar will cover:

  •     Celgene’s Revlimid - MM-020 and MM-015 trial results in newly-diagnosed multiple myeloma (MM)
  •     Array Biopharma’s ARRY-520 Phase Ib results in relapsed/refractory MM
  •     Antibodies in MM, including Genmab/Janssen’s daratumumab
  •     Ambit BioSciences’ quizartinib in AML
  •     MDS update with Array’s ARRY-614, Astex's SGI-110
  •     HDAC inhibitors development for MDS and MM
  •     B-cell inhibitors in CLL -- Gilead’s idelalisib, Pharmacyclics’ ibrutinib, Infinity’s IPI-145

Juliana Wexler specializes in cancer coverage for BioPharm Insight. Previously she was an HIV public health advocate at Jacobi Medical Center in New York, where she was involved in both research and recruiting participants for clinical trials. She has also been a research assistant at both Columbia University, as well as the University of Michigan. Juliana graduated with an individualized Bachelor’s in Health Care and Health Disparities from the University of Michigan.

About BioPharm Insight
BioPharm Insight is part of Infinata, a Financial Times Group company, and a leading provider of business intelligence solutions which also include BioPharm Clinical™, High Net Worth Insight™ and wealthmonitor™. BioPharm Insight provides subscribers with an information edge by combining the most comprehensive real-time database of companies, drugs, contacts, M&A and licensing deals, forecasts and clinical trial data with proprietary forward-looking intelligence uncovered by an independent team of investigative journalists months or even years before it breaks in mainstream media. To learn more, visit http://www.biopharminsight.com.

About Infinata, Inc.
Infinata provides personalized technology solutions to turn information into insight. Services include a comprehensive BioPharm Solutions Suite, unique Wealth Prospecting tools and innovative Custom Data Services. Infinata is a part of Mergermarket, a Financial Times Group company and a division of Pearson plc. To learn more, visit http://www.infinata.com.

Business Inquiries: Holly Burke, hburke[at]infinata[dot]com, 781-619-0131
Media Inquiries: Brenda Nashawaty, Brenda[at]nashawaty[dot]com, 617-688-3253

Read the full story at http://www.prweb.com/releases/2013/11/prweb11325293.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Biopharmaceuticals - A Global Market Overview
2. Biopharm Insight’s Respiratory Disease Report Highlights Key Drugs Coming Up for Approval or in Late-Stage Development
3. Mass Spectrometry Marketplace Discussed by Biopharm Reports in In-demand Research Study Available at MarketPublishers.com
4. World Antibiotic Resistance Market Saw Big Changes in Last Five Years, According to Biopharm Reports Study Available at MarketPublishers.com
5. Therapure Biopharma Inc. Awarded US Government Contract for Development of Anti-Nerve Gas Agent
6. Monoclonal Antibodies Market Dealmaking in Biopharma Industry Analyzed in New Research Report at ReportsnReports.com
7. BioPharm Systems Unveils Study Data Mapper to Simplify the Preparation and Reporting of Clinical Data
8. Nine Lives Media Names BioPharm Systems to the MSPmentor 501
9. BioPharm Systems to Host Webinar on Clinical Trial Supply Management with Siebel CTMS
10. BioPharm Systems to Host Webinar on Using iHelp in Oracle’s Siebel Clinical Trial Management System
11. BioPharm Systems Named to the 2012 Lead411 Technology 200 List
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... ... 30, 2017 , ... This morning, more than 275 medical ... support for an independent Vaccine Safety Commission. Five of the signers of the ... hold a press conference at 9:00 AM Friday, March 31 at the ...
(Date:3/29/2017)... ... March 29, 2017 , ... Full Contact K9, an Atlanta-based dog ... Protect Law that assists dog owners in creating legally-enforceable pet trusts for their ... the natural next step to protect their new companion. Says Evan Dunbar, CEO of ...
(Date:3/29/2017)... ... 2017 , ... Sports Brand EXOUS Bodygear announced today a special sale price ... the remaining days of March, the price will be only $19.97. The EXOUS Bodygear ... just $10 (regular retail price $19.97). , The special promotional prices are to help ...
(Date:3/29/2017)... , ... March 29, 2017 , ... ... FASTBRACES® in Carnegie, OK, from Dr. Jamie Cameron, with or without ... efficiently, compared to traditional orthodontic treatment. Depending on each patient’s case, treatment with ...
(Date:3/29/2017)... ... ... Curio Wellness , a premium medical cannabis brand and trusted healthcare ... team with prominent executives from both inside and outside the cannabis industry. , ... Dumbauld , who has more than twenty years of business leadership and investment experience ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... TOKYO , March 29, 2017  The ... unique Japanese public-private partnership formed to battle infectious ... investments totaling US$23 million* that could help deliver ... host of debilitating conditions. This ... a Phase 3 clinical trial testing a pediatric ...
(Date:3/29/2017)... leader in accelerated orthodontics, OrthoAccel ® Technologies, Inc. ... Manal Ibrahim , Kenji Ojima , Ivan ... microlecture presenters at the AcceleDent ® booth (#3037) ... Session, April 21-25, 2017. Orthodontists and their staff are ... a.m. On the opening morning of AAO exhibitions, Sat., ...
(Date:3/29/2017)... 2017 Transparency Market Research ... an exhaustive study of the U.S. substance abuse treatment ... are functional in this market at present, making ... companies, such as GlaxoSmithKline Plc., Pfizer Inc., Alkermes ... various marketing strategies to increase their visibility, the ...
Breaking Medicine Technology: